Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Patricia Ganz MD
Closed to Accrual
Patients enrolled in NCIC CTG MA.32 who had undergone definitive surgical treatment for invasive breast cancer within the previous 12 months were enrolled in NSABP NCIC CTG MA.32.F at the time of MA.32 randomization.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.